京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20225号 / 医博第4184号 / 新制||医||1019(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 伊達 洋至, 教授 Shohab YOUSSEFIAN, 教授 川村 孝 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20620号 / 医博第4269号 / 新制||医||1023(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 坂井 義治, 教授 小西 靖彦, 教授 川口 義弥 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

Laparoscopic liver resection (LLR) is an increasingly relevant treatment option for patients with resectable hepatocellular carcinoma (HCC). Orthotopic liver transplantation (OLT) has been considered optimal treatment for HCC in cirrhosis, but is challenged by rising organ scarcity. While health-related quality of life (HRQoL) and mental health are well-documented after OLT, little is known about HRQoL in HCC patients after LLR. We identified all HCC patients who underwent LLR at our hospital between 2014 and 2018. HRQoL and mental health were assessed using the Short Form 36 and the Hospital Anxiety and Depression Scale, respectively. Outcomes were compared to a historic cohort of HCC patients after OLT. Ninety-eight patients received LLR for HCC. Postoperative morbidity was 25% with 17% minor complications. LLR patients showed similar overall HRQoL and mental health to OLT recipients, except for lower General Health (p = 0.029) and higher anxiety scores (p = 0.010). We conclude that LLR can be safely performed in patients with HCC, with or without liver cirrhosis. The postoperative HRQoL and mental health are comparable to that of OLT recipients in most aspects. LLR should thus always be considered an alternative to OLT, especially in times of organ shortage.

Fibrolamellar hepatocellular carcinoma (FL-HCC) is a malignant liver tumor which is thought to be a variant of conventional hepatocellular carcinoma (HCC). It accounts for a small proportion of HCC cases and occurs in a distinctly different group of patients which are young and usually not in the setting of chronic liver disease. The diagnosis of FL-HCC requires the integration of clinical information, imaging studies, and histology. In terms of the treatment options, the only potentially curative treatment option for patients who have resectable disease is surgery either liver resection (LR) or liver transplantation (LT). When performed in a context of aggressive therapy, long-term outcomes after surgery, particularly liver resection for FL-HCC, were favorable. The clinical outcome of patients with unresectable disease is suboptimal with median survival of less than 12 months. The aim of this review is to update the available evidence on diagnosis, treatment options, outcome predictors, and recent developments of patients with this rare disease and to provide a summarized overview of the available literature.

General Abstract Objective: In April 2006, the Scottish Liver Transplant Unit (SLTU) became the first NHS transplant unit in the UK to offer the option of Living Donor Liver Transplantation (LDLT). This represented a unique opportunity to evaluate the functional and psychosocial impact of LDLT upon healthy donors and their recipients. Subsequent aims were to investigate the challenge of introducing LDLT in Scotland and to establish the perceived deterrents and attractions of the procedure. An additional aim was to evaluate the impact of Living Donor Kidney Transplantation (LDKT) upon donors and recipients. Design: A series of cross sectional and longitudinal studies were designed for the purpose of this thesis (3 quantitative, 2 qualitative, and 1 mixed methods). Method: Self report questionnaires were used in each of the quantitative studies, with the addition of neuropsychological computerized tests in two studies. Semi-structured interviews were employed in the qualitative studies. Main Findings: •Prior to its introduction general support for the option of LDLT was found, although it was highlighted that the risk involved was not well understood by the general public. •Since becoming available LDLT has not been a readily acceptable treatment option from the perspective of patients due to the perceived risk for the donor, but it may be considered as a “last option”. Family members were motivated to save their loved one’s life but the personal implications of donating resulted in reconsideration of LDLT. • Staff at the SLTU perceived a lack of family commitment in relation to LDLT, which is explained as a cultural factor contributing to the slow uptake of LDLT. In Scotland, a donation from a younger to an older generation is not easily accepted. This, in addition to patients’ optimism that a deceased donation will arrive, and the poor health of potential donors, is thought to have affected the uptake of LDLT. As has the unit’s conservative approach to the promotion of LDLT. This approach is the result of a perceived reduction in the need for LDLT and a preference to avoid the risk to a healthy donor and conduct transplants with deceased donations. • In over 3 years, only one couple completed LDLT. The recipient showed functional and psychosocial improvement from pre to post procedure, whilst the donor showed slight deterioration in aspects of quality of life 6 weeks post donation, which did not always completely return to a baseline level by 6 months. The donor made sacrifices to provide her husband with a fresh start to life and unmet expectations were found to effect quality of life. •Willingness to become a liver donor is not thought to be influenced by the frame of the information provided. •Like the LDLT donor, LDKT donors experience some functional and psychosocial deterioration at 6 weeks post donation, but donors largely recover by 6 months post donation. However, the anticipated benefit to recipients was not evident and may not be quantifiable until after 6 months post operation. Conclusion: This thesis has added to current knowledge on living organ donation and specifically represents the first psychological evaluation of a UK LDLT programme. The slow uptake of LDLT was unexpected and has resulted in informative, novel research.

La transplantation hépatique est le seul traitement définitif des enfants ayant une hépatite fulminante sans résolution spontanée. L’évolution de cette maladie dans la population pédiatrique diffère de celle adulte, particulièrement en regard de l’encéphalopathie. Pour définir les indications de transplantation hépatique, plusieurs indicateurs précoces de pronostic furent étudiés chez les adultes. Ces indicateurs n’ont pu être transposés à la population pédiatrique. Objectif primaire : Déterminer les marqueurs de risque de mortalité des enfants recevant une transplantation hépatique pour une hépatite fulminante, se définissant par une insuffisance hépatique sévère sans antécédent au cours des huit semaines précédentes. Méthode : Il s’agit d’une étude rétrospective incluant tous les enfants ayant reçu une transplantation hépatique pour une hépatite fulminante à l’hôpital Sainte-Justine entre 1985 et 2005. Le score PELOD (Pediatric Logistic Organ Dysfunction) est une mesure de sévérité clinique d’un enfant aux soins intensifs. Il fut calculé à l’admission et avant la transplantation hépatique. Résultats : Quatorze enfants (cinq mois à seize ans) reçurent une transplantation hépatique pour une hépatite fulminante. Neuf enfants (64%) survécurent et cinq (36%) décédèrent. L’utilisation de la ventilation mécanique fut associée à un mauvais pronostic (p = 0,027). Entre l’admission et la transplantation hépatique, 88% des enfants ayant eu une variation du score PELOD inférieure à cinq survécurent. Tous ceux ayant eu une variation supérieure à cinq décédèrent. (p = 0,027) Conclusion : La variation du score PELOD pourrait aider à définir un indicateur précoce de l’évolution d’un enfant après une transplantation hépatique pour une hépatite fulminante. / Hepatic transplantation is the only definitive treatment for acute liver failure for those children who do not recover spontaneously. Early indicators of prognosis in acute liver failure have been studied in adults in order to define the indication for liver transplantation. The course of the disease in the pediatric population, particularly with respect to hepatic encephalopathy, differs from that in adults. Consequently, these criteria are not applicable to the pediatric population. Primary objective: To determine the risk markers for mortality in children receiving liver transplantation for acute liver failure. Liver failure is defined as being severe failure without prior liver disease within the last eight weeks. Method: A retrospective study was conducted with children who had received a liver transplantation for acute liver failure at Sainte-Justine’s Hospital between 1985 and 2005. Data including the PELOD (Pediatric Logistic Organ Dysfunction) Score, a clinical score (0-71) of illness severity in children in intensive care, were recorded from patients’ charts. Results: 14 children, aged from five months to sixteen years old, were transplanted for fulminant liver failure. Nine (64%) survived and five (36%) died. The need for mechanical ventilation was associated with a poorer survival (p= 0,027). Of all of the children who had a PELOD Score variation inferior to five, between admission and transplantation, 88% survived. None of those with a score variation superior to five survived (p=0,027). Conclusion: In our single centre study, the PELOD Score variation was a pre-transplant marker of mortality after liver transplantation for pediatric acute liver failure.

L’attente de la greffe de foie représente une réalité stressante pour la personne atteinte d’insuffisance hépatique. En effet, l’insuffisance hépatique est une cause importante de mortalité en Amérique du Nord et la greffe de foie est considérée comme la solution salvatrice. Or, le nombre restreint de donneurs cadavériques ainsi que l’augmentation des demandes pour la transplantation conduisent à une prolongation de la durée d’attente et un accroissement du risque de mortalité des patients sur la liste d’attente pour obtenir une greffe de foie. Par ailleurs, cette longue attente est associée à une détérioration non seulement de la condition physique du patient mais aussi de sa qualité de vie. Cette étude vise à comprendre la signification de l’expérience d’attente d’une greffe de foie pour des personnes atteintes d’insuffisance hépatique. Six entrevues individuelles ont été réalisées et les données recueillies ont été analysées suivant une des méthodes décrites par Miles et Huberman (2003). Les résultats de cette étude ont démontré que le patient en attente de greffe de foie ressent un sentiment d’incertitude qui se traduit par la peur de mourir, la tristesse et la colère, l‘impatience, l’inquiétude et l’impuissance. La fatigue a aussi été identifiée comme une cause importante de frustration chez les informants. / Waiting for a liver transplantation is a stressful reality for patients with liver failure. In north America, liver failure is associated with a high risk of mortality and the liver transplantation is the only way to save the patient’s life. However, the lack of deceased donors and the high rate of demand for transplantation increase the waiting period for a liver transplantation along with the risk of mortality on the waiting list. This long waiting period is associated with a deterioration of not only the patient’s physical condition but also his quality of life. This study aims to understand the experience of waiting for a liver transplantation for patients with liver failure. Six individual interviews had been conducted and the data had been analyzed according to one of the methods described by Miles and Huberman (2003). The results had shown that the patient waiting for liver transplantation experiences a feeling of uncertainty caracterized by the fear of death, sadness and anger, impatience, worryness and powerlessness. It has also been found that fatigue is an important cause of frustration for the informants.

Introdução: A doença hepática crônica na infância aumenta o risco de deficit neurocognitivo e linguístico, que pode persistir mesmo após o transplante de fígado (TxH) bem-sucedido. O objetivo da pesquisa foi verificar se há atraso no desenvolvimento linguístico em crianças com idade entre 2 anos e 7 anos e 11 meses, pré TxH e pós TxH. Método: A casuística foi constituída por 76 crianças, sendo 31 pré TxH e 45 pós TxH. O grupo controle (GC) foi composto por 60 crianças. Para verificar as habilidades linguísticas, foi aplicado o Test of Early Language Development-TELD-3. Para complementar, foram coletados dados clínicos e socioeconômicos. Resultados: O desempenho das crianças na fila de espera do transplante foi significativamente inferior ao do GC (p < 0,001) e ao do grupo pós TxH (p < 0,001), com valores abaixo da média, de acordo com o TELD-3. O grupo pós TxH apresentou média inferior à do GC (p=0,031), entretanto, com valores na média, de acordo com o TELD-3. Na análise de regressão, para o pré TxH a idade apareceu como fator de risco (OR=1,075; p=0,050) e para o pós TxH, a renda mensal (OR = 0,999; p=0,055). Conclusões: Constatou-se atraso das habilidades gerais de linguagem em crianças pré TxH, sendo a idade o único fator de risco apontado para o atraso linguístico. Para o grupo pós TxH não foi observado atraso linguístico. Entretanto, o desempenho foi inferior ao do GC e o único fator de risco indicado foi a renda familiar mensal. É necessário que as crianças sejam acompanhadas por equipe multiprofissional no momento pré TxH e no pós TxH imediato, para minimizar os deficit linguísticos e otimizar seu desenvolvimento / Introduction: Chronic liver disease in childhood increases the risk for neurocognitive and linguistic deficits, which may persist even after successful liver transplantation (LT). The objective of the present research was to check for delayed language development in children aged 2 years to 7 years and 11 months, pre and post liver transplant. Method: The sample consisted of 76 children, 31 pre LT and 45 post LT. The control group (CG) consisted of 60 children. For checking the language skills the Test of Early Language Development-TELD-3 was administered. In addition, clinical and socioeconomic data were collected. Results: The performance of children on the waiting list for transplant was significantly lower than the control group (p < 0.001) and the post LT group (p < 0.001), with values below average according to TELD-3. The post LT group had lower scores than the CG (p = 0.031), however with values on average according to TELD-3. In the regression analysis for the pre LT group, age appeared as a risk factor (OR = 1.075; p = 0.050) and for the post LT, monthly income (OR = 0.999; p = 0.055). Conclusions: General language skills were delayed in the pre LT group, with age appearing as the only risk factor for the language delay. Language delay was not observed in the post LT group, however the performance was lower than the CG, the only risk factor indicated was monthly family income. To minimize the linguistic deficit and optimize their development, children pre LT and immediately post LT, should be assisted by a multi-professional group

O objetivo desta pesquisa é comparar a eficiência clínica dos métodos convencional ou piggyback de transplante de fígado (Tx) na reconstrução do efluxo venoso do enxerto. Adicionalmente, pretende-se comparar a eficácia da drenagem venosa do enxerto hepático em diferentes modalidades do método piggyback. Foram estudados 32 pacientes submetidos a Tx pelo método convencional (n=15) ou piggyback (n=17). A pressão da veia hepática livre (PVHL) foi medida por catéter introduzido na veia hepática direita (VHD) do enxerto e a pressão venosa central (PVC) por catéter de Swan-Ganz. As medidas de pressão foram realizadas após a revascularização do enxerto. Gradiente PVHL-PVC superior a 3 mm Hg foi encontrado em 26,7% (4/15) no grupo convencional e 17,6% (3/17) no grupo piggyback (p=0,678). A mediana do gradiente PVC-PVHL foi de 2 mm Hg (0-8 mm Hg) no grupo convencional e 3 mm Hg (0-7 mm Hg) no piggyback (p=0,734). A creatinina sérica (Cr) foi medida no pré-operatório, do 1º ao 7º dia pós-operatório (PO) e no 14º, 21º e 28º PO. A Cr global pós-operatória, calculada pela área sob a curva da Cr vs tempo, foi significativamente maior no grupo convencional (2,04 ± 0,89 vs. 1,41 ± 0,44 mg/dL; p=0,02). Não houve diferença estatisticamente significante entre os grupos quanto à ocorrência de insuficiência renal aguda (p=0,120), definida como Cr maior ou igual a 2,0 mg/dL, quanto ao desenvolvimento de ascite maciça (p=1,000) e em relação à sobrevida dos pacientes (p=0,316). O gradiente PVHL-PVC foi significativamente menor nos casos em que o óstio da VHD é utilizado para reconstrução da via de drenagem venosa no Tx piggyback (1,4 ± 1,4 mm Hg vs. 3,9 ± 1,7 mm Hg; p=0,005). Conclui-se que pacientes submetidos a Tx pelos métodos convencional e piggyback apresentam resultados semelhantes em relação à drenagem venosa do enxerto, ao desenvolvimento de ascite e à sobrevida. Os valores de Cr no PO imediato são significantemente maiores no método convencional. Nos pacientes submetidos a Tx pelo método piggyback, o gradiente PVHL-PVC é menor nos casos em que o óstio da VHD do receptor é incluído para implantação da VCI do enxerto. / The aim of this study is to compare the clinical efficiency of hepatic venous outflow reconstruction in conventional and piggyback method of liver transplantation (LTx). The efficacy of the different types of reconstruction of venous drainage in the piggyback liver transplantation was analyzed by a second purpose. Thirty two patients submitted to LTx by conventional method (n=15) or piggyback method (n=17) were studied. Free hepatic venous pressure (FHVP) was measured using a catheter introduced in right hepatic vein (RHV). Central venous pressure (CVP) was obtained through Swan-Ganz catheter. Pressure measurements were performed after graft reperfusion. A FHVP-CVP gradient higher than 3 mm Hg was observed in 26.7% (4/15) of the conventional and in 17.6% (3/17) of the piggyback patients (p=0.678). Median FHVP-CPV gradient value was 2 mm Hg (0-8 mm Hg) in the conventional and 3 mm Hg (0-7 mm Hg) in the piggyback group (p=0.734). Serum creatinine (Cr) was measured on postoperative days 1 to 7, 14, 21 and 28. Postoperative overall Cr, calculated by area under the curve of Cr vs. time, was significantly higher in conventional group (2.04 ± 0.89 vs. 1.41 ± 0.44 mg/dL; p=0.02). There is no significant difference between the groups regarding occurrence of acute renal failure (p=0,120), defined by Cr maior ou igual a 2,0 mg/dL, development of massive ascites (p=1,000) and patient survival (p=0,316). In piggyback LTx patients, FHVP-CVP gradient was significantly lower when the ostium of the RHV of the recipient is used for venous drainage reconstruction (1.4 ± 1.4 mm Hg vs. 3.9 ± 1.7 mm Hg; p=0.005). In conclusion, patients submitted to conventional or piggyback method of LTx have similar results regarding venous outflow, development of ascites and survival. The postoperative Cr values are significantly higher in conventional method. Patients submitted to piggyback LTx present a lower FHVP-CVP gradient when the ostium of the RHV of the recipient is included for implantation of the graft inferior vena cava.